Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JAKKIDI S REDDY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1780760421
CMS profile
35722
Location
ROSEVILLE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$528.11

24 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $528.11 24

By paying entity

PY2024 · entire year · sorted by reported total

Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JAKKIDI S REDDY

NPI 1780760421 · CMS profile ID 35722

Allopathic & Osteopathic Physicians / Internal Medicine

ROSEVILLE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1780760421?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JAKKIDI S REDDY, NPI 1780760421, CMS profile ID 35722. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780760421?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). JAKKIDI S REDDY, NPI 1780760421, CMS profile ID 35722. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780760421?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
JAKKIDI S REDDY, NPI 1780760421, CMS profile ID 35722, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1780760421?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

24 matching records · $528.11 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 24 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–24 of 24.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $18.1112/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097828842 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.3111/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153580953 CMS
ABBVIE INC. $19.5310/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105928143 CMS
ABBVIE INC. $25.6510/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105928141 CMS
Exact Sciences Corporation $21.5210/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114849916 CMS
PFIZER INC. $20.6809/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131989733 CMS
Novo Nordisk Inc $18.6108/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096632116 CMS
Lilly USA, LLC $19.7408/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1134990288 CMS
Novo Nordisk Inc $16.5107/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096586398 CMS
GlaxoSmithKline, LLC. $23.1206/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116469168 CMS
Janssen Pharmaceuticals, Inc $22.5606/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077936972 CMS
PFIZER INC. $22.4306/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131732355 CMS
Lilly USA, LLC $30.4505/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135016336 CMS
GlaxoSmithKline, LLC. $21.7704/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116602685 CMS
Phathom Pharmaceuticals, Inc. $25.9904/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151114897 CMS
Novo Nordisk Inc $19.0204/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097827973 CMS
Astellas Pharma US Inc $24.6004/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139334170 CMS
AstraZeneca Pharmaceuticals LP $23.6903/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105606107 CMS
Medtronic, Inc. $26.2903/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119483096 CMS
Lilly USA, LLC $15.8502/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135035636 CMS
Sumitomo Pharma America, Inc. $23.8402/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148908514 CMS
AstraZeneca Pharmaceuticals LP $22.0202/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105510321 CMS
Novo Nordisk Inc $20.2102/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096930256 CMS
GlaxoSmithKline, LLC. $21.6101/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116658037 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $655.73 31
PY2020 $558.98 29
PY2021 $549.99 25
PY2022 $556.21 25
PY2023 $613.28 28
PY2024 $528.11 24
PY2025 $800.67 33

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $547.47 1
PY2022 Principal investigator $3,173.76 2
PY2021 Principal investigator $167,966.72 10
PY2020 Principal investigator $265,419.85 28
PY2019 Recipient $3,406.00 1
PY2019 Principal investigator $435,301.69 34

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

35 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Amgen Inc. $4,548.00 12/25/2019 Non-covered Recipient Entity
SIERRA CLINIC RESEARCH
FOURIER OLE (Ph 4) No dispute reported 06/30/2026 675778541
Principal investigator 1 Novo Nordisk AS $885.38 12/19/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 692449405
Principal investigator 1 Novo Nordisk AS $470.82 12/03/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 692449403
Principal investigator 1 Novo Nordisk AS $2,745.56 10/29/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 692449397
Principal investigator 1 Amgen Inc. $12,052.88 10/24/2019 Non-covered Recipient Entity
SIERRA CLINIC RESEARCH
VESALIUS-CV No dispute reported 06/30/2026 675792365
Principal investigator 1 GlaxoSmithKline, LLC. $6,996.60 10/16/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
Not supplied No dispute reported 06/30/2026 669963939
Principal investigator 1 Janssen Research & Development, LLC $9,000.00 10/07/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects with Type 2 Diabetes Mellitus No dispute reported 06/30/2026 654258247
Principal investigator 1 Amgen Inc. $44,127.36 08/13/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
VESALIUS-CV No dispute reported 06/30/2026 675792378
Principal investigator 1 Novo Nordisk AS $2,000.00 07/30/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 692449399
Principal investigator 1 Novo Nordisk AS $1,000.00 07/30/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 692449401
Principal investigator 1 Novo Nordisk AS $3.05 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708885
Principal investigator 1 Novo Nordisk AS $1.08 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708887
Principal investigator 1 Novo Nordisk AS $5.36 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708889
Principal investigator 1 Novo Nordisk AS $4.99 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708891
Principal investigator 1 Novo Nordisk AS $2.40 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708893
Principal investigator 1 Novo Nordisk AS $2.40 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708895
Principal investigator 1 Novo Nordisk AS $5.30 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708897
Principal investigator 1 Novo Nordisk AS $49.98 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708899
Principal investigator 1 Novo Nordisk AS $9.00 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708901
Principal investigator 1 Novo Nordisk AS $60.00 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708903
Principal investigator 1 Novo Nordisk AS $6.50 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708905
Principal investigator 1 Novo Nordisk AS $9.00 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708907
Principal investigator 1 Novo Nordisk AS $36.00 07/05/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708909
Principal investigator 1 Amgen Inc. $1,388.24 07/03/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
VESALIUS-CV No dispute reported 06/30/2026 675792387
Principal investigator 1 Novo Nordisk AS $22.97 06/27/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708881
Principal investigator 1 Novo Nordisk AS $75.00 06/10/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
NN9535-4321 No dispute reported 06/30/2026 706708883
Principal investigator 1 Novartis Pharmaceuticals Corporation $2,070.00 03/29/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED EVENT DRIVEN TRIAL OF QUARTERLY SUBCUTANEOUS CANAKINUMAB IN THE PREVENTION OF RECURRENT CARDIOVASCULAR EVENTS AMONG STABLE POST MYOCARDIAL INFARCTION PATIENTS WITH ELEVATED HSCRP No dispute reported 06/30/2026 640724769
Principal investigator 1 Eli Lilly and Company $18,277.00 03/26/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 654293417
Principal investigator 1 Janssen Research & Development, LLC $2,400.00 03/04/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects with Type 2 Diabetes Mellitus No dispute reported 06/30/2026 654258245
Principal investigator 1 Amarin Pharma Inc. $7,010.00 02/25/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect of AMR101 on Cardiovascular Heath and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardio No dispute reported 06/30/2026 700952383
Principal investigator 1 Janssen Research & Development, LLC $3,000.00 02/04/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A Randomized, Double-blind Placebo-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Subjects with Type 2 Diabetes Mellitus No dispute reported 06/30/2026 654258243
Principal investigator 1 Eli Lilly and Company $16,077.68 01/31/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 654295399
Principal investigator 1 Amgen Inc. $39,834.94 01/29/2019 Non-covered Recipient Entity
SIERRA CLINIC RESEARCH
FOURIER OLE (Ph 4) No dispute reported 06/30/2026 675792359
Recipient Eli Lilly and Company $3,406.00 01/08/2019 Covered Recipient Physician A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS No dispute reported 06/30/2026 654282807
Principal investigator 1 Amgen Inc. $261,124.20 01/04/2019 Non-covered Recipient Entity
SIERRA CLINICAL RESEARCH
FOURIER OLE (Ph 4) No dispute reported 06/30/2026 675792371